Threonine–tRNA ligase 1, cytoplasmic

TARS1
Identifiers
AliasesTARS1, ThrRS, threonyl-tRNA synthetase, TARS, threonyl-tRNA synthetase 1, TTD7
External IDsOMIM: 187790; MGI: 106314; GeneCards: TARS1
Available structures
PDBOrtholog search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
6.1.1.3↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001258437
NM_001258438
NM_152295

NM_033074

RefSeq (protein)

NP_001245366
NP_001245367
NP_689508

NP_149065

Location (UCSC)Chr 5: 33.44 – 33.47 MbChr 15: 11.38 – 11.4 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Threonine–tRNA ligase 1, cytoplasmic, also called threonyl-tRNA synthetase 1, is an enzyme that in humans is encoded by the TARS1 gene. Like its relatives, TARS2 and TARS3, this enzyme functions as a threonine–tRNA ligase, which means it attaches the animo acid threonine to its corresponding transfer RNA as part of RNA-to-protein translation.

Function

Aminoacyl tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Threonyl-tRNA synthetase belongs to the class-II aminoacyl-tRNA synthetase family.

Comparison with TARS3

Cytoplasmic threonine–tRNA ligase is unique in vertebrate aminoacyl-tRNA synthetases in having a second form, TARS3 (previously called TARSL2), evolved from a gene duplication. In mice, the TARS1 enzyme is significantly more prevalent (55x in lungs, and 3x in muscles). Structurally, TARS1 functions as a homodimer, while TARS3 may instead be a component of the protein complex: multisynthetase complex (MSC). TARS1 is also smaller, 83 kD vs. 93 kD, and this has been used to infer that it is the primary target of the antibodies involved in antisynthetase syndrome.

Medical significance

Pathogenic (homozygous and compound heterozygous) mutations in TARS1 are associated with trichothiodystrophy (a type of hair fragility disorder), with the type caused by TARS1 mutation designated as: nonphotosensitive trichothiodystrophy-7 (TTD7).

References

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

  1. 1 2 3 GRCh38: Ensembl release 89: ENSG00000113407 – Ensembl, May 2017
  2. 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000022241 – Ensembl, May 2017
  3. ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. 1 2 3 "Entrez Gene: TARS threonyl-tRNA synthetase".
  6. ↑ EC 3.1.1.3
  7. ↑ Gomez MA, Ibba M (2020-04-17). "Aminoacyl-tRNA synthetases". RNA. 26 (8): 910–936. doi:10.1261/rna.071720.119. PMC 7373986. PMID 32303649.
  8. ↑ Zeng QY, Zhang F, Zhang JH, Hei Z, Li ZH, Huang MH, Fang P, Wang ED, Sun XJ, Zhou XL (2023-05-01). "Loss of threonyl-tRNA synthetase-like protein Tarsl2 has little impact on protein synthesis but affects mouse development". Journal of Biological Chemistry. 299 (5) 104704. doi:10.1016/j.jbc.2023.104704. PMC 10200997. PMID 37059185.
  9. 1 2 3 Kanaji S, Chen W, Morodomi Y, Shapiro R, Kanaji T, Yang XL (2023-03-01). "Mechanistic perspectives on anti-aminoacyl-tRNA synthetase syndrome". Trends in Biochemical Sciences. 48 (3): 288–302. doi:10.1016/j.tibs.2022.09.011. PMC 9974581. PMID 36280495.
  10. ↑ "Threonine--tRNA ligase 1, cytoplasmic". UniProt consortium. Retrieved 2026-10-01.
  11. ↑ "TRICHOTHIODYSTROPHY 7, NONPHOTOSENSITIVE; TTD7". Online Mendelian Inheritance in Man. Johns Hopkins University. Retrieved 2026-09-27.

Further reading